ROCKVILLE, Md. — November 19, 2025 — Leads & Copy — ExeGi Pharma LLC has launched Visbiome Vet GI Care+ for veterinarians and pet owners across Canada. The product is a high-potency probiotic for cats and dogs, delivering 112.5 billion live bacteria in every capsule, containing the De Simone Formulation, a proprietary eight-strain probiotic blend.
Visbiome Vet GI Care+ has received approval from Health Canada as a Veterinary Health Product (NN.O0R3).
Dr. Caroline Mansfield, PhD, DACVM at Michigan State College of Veterinary Medicine, said that pets rely on a balanced gut microbiome for digestion and immune function. Dr. Mansfield also noted that Visbiome Vet GI Care+ has clinical data supporting its potential as a tool for specialists working with pet GI issues.
Bolstered by seven clinical studies published in peer-reviewed veterinary journals and a shift toward more diet-based therapies for pet GI disorders, Visbiome Vet GI has seen growing adoption in recent years. Visbiome Vet products, unlike most veterinary probiotics, are shipped and stored cold to ensure maximum potency and have dosing tailored to the animal’s weight. The company says that today, Visbiome Vet is one of the leading veterinarian-recommended pet probiotics in the U.S.
Marc Tewey, Chief Executive Officer of ExeGi Pharma, said that Canadian vets have requested for Visbiome Vet GI Care+ to be available in Canada for several years. Tewey also stated that their formulation delivers one of the highest probiotic concentrations available and is backed by clinical research, and that they are pleased to now deliver this option to Canada.
Visbiome Vet GI Care+ will be available only through veterinarians and veterinary pharmacies. Veterinarians can source the product from major veterinary wholesalers (CDMV, Veterinary Purchasing, WDDC, and Associated Veterinary Purchasing) or directly from the manufacturer at www.VisbiomeVet.ca.
Visbiome Vet’s formulation contains an eight-strain proprietary probiotic blend that has recently been studied in canine GI concerns.
ExeGi Pharma LLC is a biotechnology company focused on developing and commercializing live biotherapeutic and probiotic medicines. The company is headquartered in Rockville, MD.
Marc Tewey
Chief Executive Officer
ExeGi Pharma
Source: ExeGi Pharma
